chr12-109393367-T-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001101421.4(MYO1H):āc.211T>Cā(p.Tyr71His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000284 in 1,585,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 31)
Exomes š: 0.000028 ( 0 hom. )
Consequence
MYO1H
NM_001101421.4 missense
NM_001101421.4 missense
Scores
9
7
1
Clinical Significance
Conservation
PhyloP100: 7.58
Genes affected
MYO1H (HGNC:13879): (myosin IH) Predicted to enable actin filament binding activity and microfilament motor activity. Predicted to be involved in actin filament organization and vesicle transport along actin filament. Predicted to be part of myosin complex. Predicted to be active in several cellular components, including actin cytoskeleton; microvillus; and vesicle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.94
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO1H | NM_001101421.4 | c.211T>C | p.Tyr71His | missense_variant | 3/32 | ENST00000310903.10 | NP_001094891.4 | |
MYO1H | XM_011538223.3 | c.163T>C | p.Tyr55His | missense_variant | 4/34 | XP_011536525.1 | ||
MYO1H | XM_047428738.1 | c.163T>C | p.Tyr55His | missense_variant | 2/31 | XP_047284694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO1H | ENST00000310903.10 | c.211T>C | p.Tyr71His | missense_variant | 3/32 | 5 | NM_001101421.4 | ENSP00000439182 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151428Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
5
AN:
151428
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000286 AC: 6AN: 209472Hom.: 0 AF XY: 0.00000893 AC XY: 1AN XY: 111924
GnomAD3 exomes
AF:
AC:
6
AN:
209472
Hom.:
AF XY:
AC XY:
1
AN XY:
111924
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000279 AC: 40AN: 1434252Hom.: 0 Cov.: 30 AF XY: 0.0000267 AC XY: 19AN XY: 710490
GnomAD4 exome
AF:
AC:
40
AN:
1434252
Hom.:
Cov.:
30
AF XY:
AC XY:
19
AN XY:
710490
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151428Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73966
GnomAD4 genome
AF:
AC:
5
AN:
151428
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
73966
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2023 | The c.163T>C (p.Y55H) alteration is located in exon 2 (coding exon 2) of the MYO1H gene. This alteration results from a T to C substitution at nucleotide position 163, causing the tyrosine (Y) at amino acid position 55 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D
REVEL
Pathogenic
Sift
Pathogenic
.;D
Sift4G
Uncertain
D;D
Vest4
MutPred
0.78
.;Gain of catalytic residue at Q56 (P = 9e-04);
MVP
MPC
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at